dc.contributor.author |
Van De Pas, Remco |
|
dc.contributor.author |
Widdowson, Marc-Alain |
|
dc.contributor.author |
Ravinetto, Raffaella |
|
dc.contributor.author |
N Srinivas, Prashanth |
|
dc.contributor.author |
Ochoa Woodell, Theresa Jean |
|
dc.contributor.author |
Fofana, Thierno Oumar |
|
dc.contributor.author |
Van Damme, Wim |
|
dc.date.accessioned |
2021-12-12T20:24:56Z |
|
dc.date.available |
2021-12-12T20:24:56Z |
|
dc.date.issued |
2021 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/10244 |
|
dc.description.abstract |
INTRODUCTION: The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID-19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines. AREAS COVERED: This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment. EXPERT OPINION: All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool and supported by a just Intellectual Property regime. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Taylor and Francis |
|
dc.relation.ispartofseries |
Expert Review of Vaccines |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
low-income countries |
en_US |
dc.subject |
ACT-A |
en_US |
dc.subject |
capacity development |
en_US |
dc.subject |
COVID-19 pandemic |
en_US |
dc.subject |
research & development ecosystem |
en_US |
dc.subject |
Tanahashi health systems framework |
en_US |
dc.subject |
technology transfer |
en_US |
dc.subject |
TRIPS |
en_US |
dc.subject |
vaccine equity |
en_US |
dc.title |
COVID-19 vaccine equity: a health systems and policy perspective. |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1080/14760584.2022.2004125 |
|
dc.relation.issn |
1744-8395 |
|